scispace - formally typeset
N

Nicola Andina

Researcher at University of Bern

Publications -  20
Citations -  1003

Nicola Andina is an academic researcher from University of Bern. The author has contributed to research in topics: Medicine & Immunology. The author has an hindex of 7, co-authored 12 publications receiving 842 citations. Previous affiliations of Nicola Andina include University Hospital of Basel.

Papers
More filters
Journal ArticleDOI

Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense

TL;DR: It is shown that lipopolysaccharide from Gram-negative bacteria activates interleukin-5 (IL-5)- or interferon-γ–primed eosinophils to release mitochondrial DNA in a reactive oxygen species–dependent manner, but independent of eosInophil death, suggesting a previously undescribed mechanism of eOSinophil-mediated innate immune responses that might be crucial for maintaining the intestinal barrier function after inflammation-associated epithelial cell damage
Journal ArticleDOI

Induction of Bim limits cytokine-mediated prolonged survival of neutrophils.

TL;DR: A functional role for Bim is demonstrated in the regulation of neutrophil apoptosis and it is suggested that GM-CSF and other neutrophils hematopoietins initiate a proapoptotic counterregulation that involves upregulation of Bim.
Journal ArticleDOI

Proviral integration site for Moloney murine leukemia virus 1, but not phosphatidylinositol-3 kinase, is essential in the antiapoptotic signaling cascade initiated by IL-5 in eosinophils.

TL;DR: Pim-1, but not PI3K, plays a major role in IL-5-mediated antiapoptotic signaling in eosinophils, as identified by using specific protein transfer.
Journal ArticleDOI

Increased cardiovascular comorbidities in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia presenting with systemic inflammatory and autoimmune manifestations.

TL;DR: A significant association of SIAMs with cardiovascular comorbidities but without influence on progression or survival was identified, despite patient heterogeneity and small cohort size.